Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

ACTU - Actuate Therapeutics Inc.

IEX Last Trade
8.05
-0.080   -0.994%

Share volume: 38,434
Last Updated: Fri 30 Aug 2024 09:58:27 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$8.13
-0.08
-0.98%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-0.37%
1 Month
-6.50%
3 Months
-6.50%
6 Months
-6.50%
1 Year
-6.50%
2 Year
-6.50%
Key data
Stock price
$8.05
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$7.33 - $10.16
52 WEEK CHANGE
-$0.07
MARKET CAP 
154.286 M
YIELD 
N/A
SHARES OUTSTANDING 
19.166 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.86
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$45,701
AVERAGE 30 VOLUME 
$46,518
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news